MedTrace Logo

Effect of BrainPhyt High Dose on Cognitive Function in Healthy Older Individuals

NCT05759910 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-11-08

No results posted yet for this study

Summary

The purpose of this study is to evaluate if BrainPhyt, a microalgae based ingredient may affect cognitive function parameters in older healthy individuals with evidence of age-related cognitive decline.

In a double blind, randomized manner, 40 free living males and females between 55 to 75 years with age-associated memory decline will ingest Brainphyt supplement or Placebo for 12 weeks. Cognitive function battery will be realized after 4 and 12 weeks of supplementation.

Conditions

  • Age-associated Memory Impairment

Interventions

DIETARY_SUPPLEMENT

Brainphyt high dose

Participants will take BrainPhyt capsules during 3 months

DIETARY_SUPPLEMENT

Placebo

Participants will take placebo capsules during 3 months

Sponsors & Collaborators

Principal Investigators

  • Richard Kreider, PhD · Texas A&M University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-01
Primary Completion
2023-10-01
Completion
2023-11-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05759910 on ClinicalTrials.gov